VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Viskase Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$4.05−0.09 (-2.27%)

Close on Oct 19, 2026

Market cap: $58.04M
P/E (TTM): –
Dividend yield: 0.00%

Viskase Holdings, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Depreciation & Amortization	4.42	4.23	–	–	4.91	5.38	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Stock-Based Compensation	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Income Taxes	0.07	0.03	0.03	0.02	0.04	0.02	0.29	0.05	0.00	0.00	-0.25	0.08	0.05	-0.04	-0.20	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	1.15	-0.33	2.12	0.42	5.25	0.67
Change in Accounts Receivable	-4.88	-3.42	–	–	5.65	-1.19	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Change in Inventory	-7.10	-3.32	–	–	11	-5.66	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Change in Accounts Payable	1.40	-4.53	–	–	-9.09	3.66	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Cash Flow	-11	-16	-0.68	-4.70	2.24	0.13	0.23	0.40	0.24	0.25	0.46	0.43	0.25	0.17	0.13	0.06	-0.64	-0.21	-0.25	-0.30	0.00	0.05	-0.43	-0.42	0.77	-0.30	0.74	6.65	-0.19	-0.29	-0.23	-0.24	-0.27	-0.24	3.16	-0.25	3.13	0.44	1.38	1.67
Capital Expenditures	-7.70	-8.99	–	–	-8.99	-7.35	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-7.70	-8.99	–	–	-8.99	-7.35	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Dividends Paid	–	–	0	0	0	-1.28	0	0	0	-1.28	0	0	0	-1.28	–	0	–	–	–	–	–	–	0	0	–	–	-5.31	0	0	-2.65	0	0	0	0	0	–	–	–	-6.63	0
Stock Issued	0	15	–	–	0	15	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Debt Issued	0	0.65	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Taxes Paid on Share-Based Awards	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0
Financing Cash Flow	-1.75	45	0	-18	9.65	7.19	0	0	0	-1.28	0	0	0	-1.28	–	0	–	–	0	–	–	–	43	-0.30	–	–	-5.31	0	0	-2.65	0	0	0	0	0	–	–	–	-6.63	0
Foreign Exchange Rate Adjustments	-0.06	-0.05	–	–	0.26	0.08	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Change in Cash	-21	19	-0.68	-6.81	3.16	0.05	0.23	0.40	0.24	-1.02	0.46	0.43	0.25	-1.11	0.13	0.06	-0.64	-0.21	-0.25	-0.30	0.00	0.05	43	-0.42	0.77	-0.30	-4.57	6.65	-0.19	-2.94	-0.23	-0.24	-0.27	-0.24	3.16	-6.89	3.13	0.44	-5.26	1.67
Free Cash Flow	-19	-25	–	–	-6.75	-7.22	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Income Taxes Paid	2.20	0.32	0.00	-0.20	-0.08	0.28	0.00	0	0	0	–	0	0	0	–	0.00	0	0	–	0	0	0	–	0	0	0	–	0	-2.00	2.00	0	0.00	–	–	–	–	0.04	0.10	135	0.14
Interest Paid	2.30	2.39	–	-5.27	2.67	2.61	–	0	0	0	–	0	0	0	–	0	0	0	–	0	0	0	–	–	0	0	–	0	0	0	–	0	0	0	–	0	0	0	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -4.6%

Financial strength

Current ratio: 1.84
Debt to equity: 0.98
Debt to assets: 43.3%
Cash to current liabilities: 6.4%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.31
Dividend yield: 0.00%